Editorial: Update on the diagnosis and surgical treatment of gynecological tumors

Clicks: 1
ID: 310138
2025
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal

Ranked #454 of 490 articles by views in Frontiers in surgery

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 490 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Gynecological tumors, including malignancies of the ovaries, uterus, cervix, vulva, and vagina, account for a substantial proportion of cancer-related morbidity and mortality among women worldwide [1]. Recent progress in diagnostic techniques and surgical interventions has significantly impacted clinical practice, contributing to earlier detection, better risk stratification, and more tailored therapeutic strategies.Advances in imaging technologies, have improved the accuracy of preoperative tumor characterization. These tools facilitate precise staging, of gynecologic malignancies [2].Simultaneously, molecular diagnostics and next-generation sequencing are now integral in the management of ovarian and endometrial cancers. Identification of pathogenic variants such as BRCA1/2, TP53, and mismatch repair (MMR) gene deficiencies allows for more refined classification and targeted treatment planning [3][4][5][6].Emerging diagnostic modalities, such as liquid biopsy, offer non-invasive means for detecting circulating tumor DNA (ctDNA) and other tumor-derived markers, providing a promising approach for monitoring disease recurrence and therapeutic response in real-time [7]. Other promising technologies are actually available as non-coding RNAs (ncRNAs) in gynecologic malignancies, particularly endometrial cancer [8]. While still undergoing validation for widespread clinical use, early studies show considerable potential in gynecologic oncology.Surgical treatment remains the primary modality for most gynecologic cancers. Over the past decade, a paradigm shift toward minimally invasive surgery (MIS) has occurred, with laparoscopic and robotic-assisted techniques increasingly preferred due to their favorable perioperative outcomes.Studies have demonstrated equivalent oncologic safety in selected early-stage endometrial and cervical cancers, along with reduced morbidity and shorter recovery times [9][10][11].Robotic-assisted surgery, in particular, has gained prominence due to its enhanced visualization, dexterity, and ergonomics. While the upfront costs remain a limiting factor, the technology continues to expand, particularly in high-volume centers. For complex cases, such as radical hysterectomy or staging for high-grade endometrial carcinoma, robotics offer technical advantages that may translate into improved functional outcomes, especially when nerve-sparing procedures are employed [12].The management of gynecologic cancers is inherently multidisciplinary. Tumor boards that integrate surgical oncologists, medical oncologists, pathologists, radiologists, and reproductive specialists have become essential in guiding individualized treatment plans. Concurrently, artificial intelligence is beginning to influence diagnostic imaging and risk prediction models, although clinical integration is still in its early stages.The diagnosis and surgical treatment of gynecological tumors continue to evolve, driven by technological innovation, molecular medicine, and a growing emphasis on patient-centered care.
Reference Key
imported_1768922193_696f9c5169bb3 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Restaino, S.
Journal Frontiers in surgery
Year 2025
DOI
10.3389/fsurg.2025.1665026
URL
https://www.frontiersin.org/journals/surgery/articles/10.3389/fsurg.2025.1665026/full
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.